Yasuhiko Yamamoto
Papers
1
Total Citations
53
H-Index
1
About
Yasuhiko Yamamoto is a leading figure in diabetes and nephropathy research, with a primary focus on the molecular mechanisms driving diabetic complications. His major contributions center on the role of advanced glycation end products (AGEs) in kidney disease, particularly their interplay with cellular stress responses. In his highly cited 2004 study (53 citations), Yamamoto demonstrated that AGEs upregulate the collagen-specific chaperone HSP47 in mouse diabetic nephropathy, and that the AGE inhibitor OPB-9195 can suppress this effect, offering a potential therapeutic pathway. This work has been instrumental in linking protein glycation to fibrotic processes in the kidney, influencing subsequent studies on diabetic complications. Yamamoto’s research has garnered significant attention, with his most-cited paper serving as a cornerstone for understanding how AGEs drive pathological collagen accumulation. His findings have not only advanced basic science but also informed clinical strategies for managing diabetic kidney disease, making him a respected authority in the field.
Research Focus
Key Achievements
Top Papers
- 1